MetaDx
Next-generation pet healthcare solution.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | KRW500m | Seed | |
| Total Funding | 000k | ||
Related Content
MetaDx, a South Korean company established in March 2024, is focused on the veterinary diagnostics market, providing artificial intelligence-driven solutions to enhance pet healthcare. The company was founded by Chris Kim, who serves as the CEO, and Giup Jang, the CTO. The firm operates from its headquarters in Seoul, with an R&D center in Gyeonggi-do and a U.S. office in San Jose, California. Since its inception, MetaDx has secured several accolades in 2024, including the KDB Startup Excellence Award and selection for the Korea Investment Accelerator program, underscoring its early-stage traction.
The company's business model is centered on developing and providing advanced diagnostic tools directly to veterinary professionals. MetaDx aims to standardize diagnostic capabilities by creating technologies that serve veterinarians, pets, and their owners. The market focus is on pet technology, specifically within the life sciences and artificial intelligence sectors. Revenue is generated through the sale of its diagnostic products and associated software solutions to veterinary clinics and hospitals. The company has engaged in multiple funding rounds, including a seed round in October 2024 led by Korea Investment Accelerator, to fuel its research and development and market expansion efforts.
MetaDx offers a suite of products designed for early and accurate detection of pet health issues. One of its core products, CancerVET, is a diagnostic tool that analyzes biomarkers in a pet's serum to detect the presence of tumors. Another key offering is VitalVET, an AI-powered software that analyzes real-time vital signs from anesthesia monitoring equipment. This system is designed to predict potential anesthesia emergencies, identify their causes, and recommend appropriate actions to the veterinary team. By leveraging AI to analyze biological markers, the company provides veterinarians with tools to make more informed decisions and optimize treatment plans.
Keywords: veterinary diagnostics, AI in pet healthcare, pet cancer detection, animal health, anesthesia monitoring for pets, veterinary technology, Chris Kim, Giup Jang, CancerVET, VitalVET, biomarker analysis, Seoul startup, pet-tech, veterinary AI, diagnostic solutions, animal diagnostics